Cambridge, UKApr 2022
Regulatory Genome Development raised €5.5M in a Seed round in Apr 2022. The company is based in Cambridge, UK. Investors in the round: AlbionVC, Cambridge Enterprise, Evolution Equity Partners and 1 other. Data as of Nov 2026.
Amount raised
€5.5M
€5,511,953
Native amount
4,600,000 GBP
Stage
Seed
seed
Investors
4
Provenance & confidence
High confidenceAmount
4,600,000 GBP
ECB-at-date → €5.5M · rate 0.83455 on 2022-04-12
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
4 namedDate
Apr 2022
Round type
seed
Amount (EUR)
€5.5M
Other rounds
same companyThis is the company's only recorded round.
Related news
- Mastercard joins Cambridge Uni spinout’s £4.6m seed roundbusinesscloud.co.uk · 2022-04